Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REVascularisation for Ischaemic VEntricular Dysfunction (REVIVED): a Randomized Comparison of Percutaneous Coronary Intervention (With Optimal Medical Therapy) Versus Optimal Medical Therapy Alone for Treatment of Heart Failure Secondary to Coronary Disease

NCT01920048 is registered in ClinicalTrials.gov with King's College London as lead sponsor.

NCT NCT01920048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01920048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REVascularisation for Ischaemic VEntricular Dysfunction (REVIVED): a Randomized Comparison of Percutaneous Coronary Intervention (With Optimal Medical Therapy) Versus Optimal Medical Therapy Alone for Treatment of Heart Failure Secondary to Coronary Disease
Lead sponsor
King's College London
Phase
Not applicable
Overall status
Completed
Start date
August 28, 2013
Completion date
March 31, 2022
Enrollment
700 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic cardiomyopathy